M. Rinella
Epidemiology · 2015–2024
A researcher in the Science corpus: 12 papers; trusts 16 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 330 citations into it; #771 of 2,148 by trust here, #511 by citations
- Endocrinology, Diabetes and Metabolism — 223 citations into it; #208 of 623 by trust here, #177 by citations
- Hepatology — 183 citations into it; #38 of 151 by trust here, #59 by citations
- Pathology and Forensic Medicine — 56 citations into it
- Biochemistry — 11 citations into it
Whom M. Rinella trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Z. Younossi
- A. Sanyal
- D. Kleiner
- V. Ratziu
- B. Neuschwander‐Tetri
- N. Chalasani
- L. Adams
- E. Brunt
- S. Harrison
- G. Targher
Who trusts M. Rinella overall
Papers from M. Rinella's perspective
Ordered by how strongly the researchers M. Rinella trusts endorse each paper. Same corpus, a different order for every researcher.
- ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
- Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Hepatology)
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
- Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients (Hepatology)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
- Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
- 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (Alimentary Pharmacology and Therapeutics)
Their papers
- A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. (2024) — 1,246 citations
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (2023) — 1,742 citations
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature (2023) — 2,276 citations
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature. (2023) — 2,621 citations
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). (2022) — 814 citations
- Non-alcoholic fatty liver disease (2021) — 1,241 citations
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
- NAFLD 2020: The State of the Disease. (2020) — 883 citations
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. (2019) — 1,024 citations
- Mechanisms of NAFLD development and therapeutic strategies (2018) — 3,682 citations
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018) — 6,253 citations
- Nonalcoholic fatty liver disease: a systematic review. (2015) — 2,167 citations